- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- September 2026
- 181 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- January 2026
- 550 Pages
Global
From €4509EUR$5,000USD£3,867GBP
- Report
- July 2026
- 120 Pages
Global
From €4284EUR$4,750USD£3,673GBP
- Report
- July 2026
- 120 Pages
Global
From €4284EUR$4,750USD£3,673GBP
- Report
- January 2026
- 110 Pages
Global
From €4284EUR$4,750USD£3,673GBP
- Report
- August 2026
- 160 Pages
Global
From €2994EUR$3,320USD£2,568GBP
€3743EUR$4,150USD£3,209GBP
- Report
- August 2026
- 160 Pages
Global
From €2994EUR$3,320USD£2,568GBP
€3743EUR$4,150USD£3,209GBP
- Report
- October 2025
- 150 Pages
Global
From €4374EUR$4,850USD£3,751GBP
- Report
- November 2025
- 210 Pages
Global
From €4374EUR$4,850USD£3,751GBP
- Report
- November 2025
- 103 Pages
Global
From €3500EUR$4,157USD£3,106GBP
- Report
- February 2026
- 191 Pages
Global
From €4374EUR$4,850USD£3,751GBP
- Report
- January 2026
- 150 Pages
Global
From €4374EUR$4,850USD£3,751GBP
- Report
- June 2026
- 230 Pages
United States
From €4284EUR$4,750USD£3,673GBP
- Report
- October 2025
- 80 Pages
Middle East
From €4058EUR$4,500USD£3,480GBP
- Report
- January 2022
- 294 Pages
Global
From €4328EUR$4,799USD£3,711GBP

The Peptide Therapeutic market is a subset of the Proteomics industry, which focuses on the study of proteins and their functions. Peptide Therapeutics are a type of drug that are composed of short chains of amino acids, and are used to treat a variety of diseases. These drugs are typically used to target specific proteins in the body, and can be used to treat conditions such as cancer, diabetes, and autoimmune diseases. Peptide Therapeutics are often used in combination with other drugs, such as chemotherapy, to maximize their effectiveness.
The Peptide Therapeutic market is highly competitive, with many companies developing and marketing these drugs. Some of the major players in the market include Amgen, Merck, Novartis, Pfizer, and Sanofi. Other companies such as AbbVie, AstraZeneca, and Eli Lilly are also active in the market. Show Less Read more